Surgical Management of Hereditary Breast Cancer

The identification that breast cancer is hereditary was first described in the nineteenth century. With the identification of the BRCA1 and BRCA 2 breast/ovarian cancer susceptibility genes in the mid-1990s and the introduction of genetic testing, significant advancements have been made in tailoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Elizabeth R., Golshan, Mehra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470490/
https://www.ncbi.nlm.nih.gov/pubmed/34573353
http://dx.doi.org/10.3390/genes12091371
_version_ 1784574212921360384
author Berger, Elizabeth R.
Golshan, Mehra
author_facet Berger, Elizabeth R.
Golshan, Mehra
author_sort Berger, Elizabeth R.
collection PubMed
description The identification that breast cancer is hereditary was first described in the nineteenth century. With the identification of the BRCA1 and BRCA 2 breast/ovarian cancer susceptibility genes in the mid-1990s and the introduction of genetic testing, significant advancements have been made in tailoring surveillance, guiding decisions on medical or surgical risk reduction and cancer treatments for genetic variant carriers. This review discusses various medical and surgical management options for hereditary breast cancers.
format Online
Article
Text
id pubmed-8470490
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84704902021-09-27 Surgical Management of Hereditary Breast Cancer Berger, Elizabeth R. Golshan, Mehra Genes (Basel) Review The identification that breast cancer is hereditary was first described in the nineteenth century. With the identification of the BRCA1 and BRCA 2 breast/ovarian cancer susceptibility genes in the mid-1990s and the introduction of genetic testing, significant advancements have been made in tailoring surveillance, guiding decisions on medical or surgical risk reduction and cancer treatments for genetic variant carriers. This review discusses various medical and surgical management options for hereditary breast cancers. MDPI 2021-08-31 /pmc/articles/PMC8470490/ /pubmed/34573353 http://dx.doi.org/10.3390/genes12091371 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Berger, Elizabeth R.
Golshan, Mehra
Surgical Management of Hereditary Breast Cancer
title Surgical Management of Hereditary Breast Cancer
title_full Surgical Management of Hereditary Breast Cancer
title_fullStr Surgical Management of Hereditary Breast Cancer
title_full_unstemmed Surgical Management of Hereditary Breast Cancer
title_short Surgical Management of Hereditary Breast Cancer
title_sort surgical management of hereditary breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470490/
https://www.ncbi.nlm.nih.gov/pubmed/34573353
http://dx.doi.org/10.3390/genes12091371
work_keys_str_mv AT bergerelizabethr surgicalmanagementofhereditarybreastcancer
AT golshanmehra surgicalmanagementofhereditarybreastcancer

Ejemplares similares